These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Approaches to treatment of HIV facial lipoatrophy. Jones D Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459 [TBL] [Abstract][Full Text] [Related]
29. Industrial-grade silicone injections causing intermittent bilateral malar swelling: review of safety and efficacy of techniques and products available. Seward AC; Meara DJ J Oral Maxillofac Surg; 2013 Jul; 71(7):1245-8. PubMed ID: 23522770 [TBL] [Abstract][Full Text] [Related]
30. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation. Lizzul PF; Narurkar VA J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786 [TBL] [Abstract][Full Text] [Related]
31. The Canadian experience with fillers. Burchard AE; Ellis DA Facial Plast Surg; 2009 May; 25(2):129-34. PubMed ID: 19415582 [TBL] [Abstract][Full Text] [Related]
32. Filling agents. Glavas IP Ophthalmol Clin North Am; 2005 Jun; 18(2):249-57, v-vi. PubMed ID: 15935286 [TBL] [Abstract][Full Text] [Related]
33. Complications after treatment with polyalkylimide. Schelke LW; van den Elzen HJ; Canninga M; Neumann MH Dermatol Surg; 2009 Oct; 35 Suppl 2():1625-8. PubMed ID: 19807756 [TBL] [Abstract][Full Text] [Related]
34. Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs. Treacy PJ; Goldberg DJ Dermatol Surg; 2006 Jun; 32(6):804-8. PubMed ID: 16792645 [TBL] [Abstract][Full Text] [Related]
35. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations. Smith KC Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563 [TBL] [Abstract][Full Text] [Related]
36. Soft tissue augmentation 2006: filler fantasy. Klein AW Dermatol Ther; 2006; 19(3):129-33. PubMed ID: 16784511 [TBL] [Abstract][Full Text] [Related]
37. Ten-Year and Beyond Follow-up After Treatment With Highly Purified Liquid-Injectable Silicone for HIV-Associated Facial Lipoatrophy: A Report of 164 Patients. Jones DH; Carruthers A; Brody HJ; Black JM; Humphrey S; Carruthers J; Wesley NO; Minokadeh A Dermatol Surg; 2019 Jul; 45(7):941-948. PubMed ID: 30893157 [TBL] [Abstract][Full Text] [Related]
38. Restorative interventions for HIV facial lipoatrophy. Carey D; Liew S; Emery S AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122 [TBL] [Abstract][Full Text] [Related]
39. Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients. Pavicic T; Ruzicka T; Korting HC; Gauglitz G J Drugs Dermatol; 2010 Jun; 9(6):690-5. PubMed ID: 20645533 [TBL] [Abstract][Full Text] [Related]